The BIO Investor Forum Links Promising Early-Stage Technologies with an Active Investor Network
BIOtech Now Nareg Sagherian As the biopharma industry has gained traction on new drug approvals throughout 2019, the financial dollars have followed […]
BIOtech Now Nareg Sagherian As the biopharma industry has gained traction on new drug approvals throughout 2019, the financial dollars have followed […]
BIOtech Now Andrew Segerman The Biotechnology Innovation Organization (BIO), leading scientists, public policy experts, and industry leaders today announced the launch of […]
BIOtech Now Andrew Segerman BIO’s Jim Greenwood joined CSPAN’s Washington Journal for a conversation about drug pricing, the latest proposals being considered […]
BIOtech Now Andrew Segerman Writing for STAT News, Paul Hastings – CEO of Nkarta Therapeutics and Vice Chair of BIO’s Board – […]
BIOtech Now Andrew Segerman BIO is out with a new whiteboard video that explores why more and more patients are facing higher […]
BIOtech Now Josh Falzone Every year, mosquitos infect 500 million people with diseases and mosquito-borne illnesses claim nearly a million lives. Mosquito-related […]
BIOtech Now Andrew Segerman Experts recently gathered on Capitol Hill to discuss how importing foreign price controls will lead to less innovation […]
BIOtech Now BIOtechNOW Editor Continued access to a stable treatment can make all the difference for patients with chronic illnesses like arthritis, […]
BIOtech Now Andrew Segerman In a recent study published by Tufts University, researchers found that rare disease drug development is now one […]
BIOtech Now Andrew Segerman In a piece for Morning Consult, BIO’s Jim Greenwood writes that while CAR-T cell therapies are changing the […]
BIOtech Now admin In just two years, BIO Ventures for Global Health (BVGH) has made significant progress in responding to the growing […]
BIOtech Now Sesquile Ramon In today’s increasingly connected world, health care researchers have access to previously unimaginable troves of data about the […]
BIOtech Now Andrew Segerman In his a recent piece for Bloomberg, reporter Robert Langreth paints a harrowing picture of the quickly deteriorating […]
BIOtech Now Jeremy Isenberg Neurological disorders are estimated to affect up to 1 billion people around the world—including nearly 100 million Americans—with […]
BIOtech Now Theresa Brady “The world is beginning to grasp that we’ve entered the dawn of a golden age of medicine. It’s […]
BIOtech Now BIOtechNOW Editor Some 95 percent of cancer drugs launched around the globe are available in the U.S. Given that the […]
BIOtech Now Jeremy Isenberg Drug overdose deaths, including those involving opioids, reached 42,000 in 2016 (CDC), prompting a national response from the […]
BIOtech Now Theresa Brady It’s obvious that cost presents a major burden for patient access to gene therapy. The recent approval of […]
BIOtech Now Andrew Segerman The next big medical breakthrough is on the horizon and all it takes is one idea, one vision, […]
BIOtech Now Andrew Segerman The next big medical breakthrough is on the horizon and all it takes is one idea, one vision, […]
